跳至主要内容
临床试验/JPRN-UMIN000018947
JPRN-UMIN000018947已完成未知

A Study on Predictors of Treatment Response to Sofosbuvir and Ribavirin Therapy in Patients with genotype 2 Chronic Hepatitis C Virus Infection - Predictor of treatment response to SOF /RBV therapy

Hokkaido University Department of Gastroenterology and Hepatology, Graduate School of Medicine,0 个研究点目标入组 260 人开始时间: 2015年9月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Patients with poorly controlled cardiac disease; e.g. myocardial infarction, cardiac failure, arrhythmia 2 Patients with severe hepatic impairment 3 Patients with a history of hypersensitivity to HCV NS5B inhibitors or Ribavirin 4 Patients with a concurrent malignancy, including hepatocellular carcinoma, at the start of treatment 5 Patients deemed unsuitable for Study entry by their treating physician 6 Patients with severe renal dysfunction

研究者

发起方
Hokkaido University Department of Gastroenterology and Hepatology, Graduate School of Medicine,

相似试验

A Study on Predictors of Treatment Response to... | 临床试验